Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Payables: 2017-2025

Historic Payables for Organogenesis Holdings (ORGO) over the last 7 years, with Sep 2025 value amounting to $40.2 million.

  • Organogenesis Holdings' Payables rose 67.78% to $40.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $123.5 million, marking a year-over-year increase of 15.09%. This contributed to the annual value of $28.9 million for FY2024, which is 5.90% down from last year.
  • As of Q3 2025, Organogenesis Holdings' Payables stood at $40.2 million, which was up 35.31% from $29.7 million recorded in Q2 2025.
  • Organogenesis Holdings' 5-year Payables high stood at $40.2 million for Q3 2025, and its period low was $23.2 million during Q1 2024.
  • Moreover, its 3-year median value for Payables was $28.9 million (2024), whereas its average is $28.7 million.
  • Its Payables has fluctuated over the past 5 years, first fell by 29.43% in 2023, then skyrocketed by 67.78% in 2025.
  • Quarterly analysis of 5 years shows Organogenesis Holdings' Payables stood at $29.3 million in 2021, then climbed by 10.19% to $32.3 million in 2022, then decreased by 4.97% to $30.7 million in 2023, then decreased by 5.90% to $28.9 million in 2024, then skyrocketed by 67.78% to $40.2 million in 2025.
  • Its last three reported values are $40.2 million in Q3 2025, $29.7 million for Q2 2025, and $24.7 million during Q1 2025.